DCT

1:26-cv-08351

Natural Extraction Systems LLC v. Green Thumb Industries Inc

Log In
Key Events
Complaint
complaint Intelligence

I. Executive Summary and Procedural Information

  • Parties & Counsel:
  • Case Identification: Natural Extraction Systems, LLC v. Green Thumb Industries Inc., 1:26-cv-08351, S.D. Fla., 01/12/2026
  • Venue Allegations: Plaintiff alleges venue is proper in the Southern District of Florida because Defendants maintain established places of business in the district, including a marijuana processing facility in Miami-Dade County and multiple "RISE" dispensaries, and have committed the alleged acts of infringement within the district.
  • Core Dispute: Plaintiff alleges that Defendants' processes for producing cannabis distillates, and the resulting products sold under brands such as RYTHM and &Shine, infringe four patents related to methods for chemically modifying cannabinoids through gas-phase decarboxylation.
  • Technical Context: The technology concerns methods for converting acidic, non-psychoactive cannabinoids (like THCA) from cannabis plants into their active forms (like THC) through a rapid, gas-phase heating and condensation process designed to maximize purity and minimize undesirable byproducts.
  • Key Procedural History: All four asserted patents claim priority to a single U.S. Provisional Patent Application filed on August 10, 2018. The complaint extensively details Defendants' corporate structure, alleging the parent company GTI exercises significant control over its Florida-based subsidiaries, forming the basis for an alter ego liability theory.

Case Timeline

Date Event
2018-08-10 Priority Date for '248, '402, '181, and '214 Patents (Provisional Application No. 62/717,235 filing)
2020-06-02 U.S. Patent No. 10,669,248 Issues
2023-05-09 U.S. Patent No. 11,643,402 Issues
2025-05-13 U.S. Patent No. 12,297,181 Issues
2025-09-23 U.S. Patent No. 12,420,214 Issues
2026-01-12 Complaint Filed

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 10,669,248 - "Methods to Chemically Modify Cannabinoids"

The Invention Explained

  • Problem Addressed: The patent addresses the issue that traditional methods for producing active cannabinoids, such as THC, require prolonged heating for decarboxylation, a process that also degrades the product and creates undesirable byproducts like cannabinol (CBN), which causes drowsiness '248 Patent, col. 1:15-33
  • The Patented Solution: The invention proposes a method to rapidly decarboxylate cannabinoid carboxylic acids (e.g., THCA) by performing the reaction in the gas phase. A composition containing the native cannabinoid is contacted with sufficient energy to vaporize and convert it simultaneously, after which the resulting modified cannabinoid gas (e.g., THC) is immediately condensed on a heat sink to collect a liquid distillate. The patent theorizes this gas-phase reaction lowers the activation energy required for decarboxylation '248 Patent, abstract '248 Patent, col. 5:8-11
  • Technical Importance: This method purports to enable near-stoichiometric conversion of cannabinoids while minimizing thermal degradation, aiming to produce a higher-purity, higher-yield final product with fewer undesirable side effects '248 Patent, col. 6:5-15

Key Claims at a Glance

  • The complaint asserts independent claims 1, 2, 8, and 12 Compl. ¶191
  • The essential elements of independent claim 1 include:
    • providing a composition comprising a native cannabinoid molecule with a carboxyl group in a liquid or solid phase;
    • contacting the composition with sufficient energy to convert the native molecule into a modified molecule in a gas phase;
    • contacting the modified molecule with a heat sink to condense it into a liquid distillate, achieving at least 95% conversion of the native molecule per mole; and
    • collecting the liquid distillate.

U.S. Patent No. 11,643,402 - "Gas Phase Methods to Decarboxylate Cannabinoids"

The Invention Explained

  • Problem Addressed: The patent identifies the same problem as the '248 Patent: conventional prolonged heating for decarboxylation is inefficient and creates unwanted chemical modifications '402 Patent, col. 1:21-30
  • The Patented Solution: The '402 Patent builds on the gas-phase decarboxylation concept by adding a specific geometric requirement: the starting cannabinoid composition must be provided with a surface-area-to-volume ratio greater than 1000 per meter. This high ratio, characteristic of a thin film, is intended to optimize energy transfer and facilitate a more efficient and rapid gas-phase conversion and subsequent condensation '402 Patent, claim 1 '402 Patent, col. 2:30-43
  • Technical Importance: By specifying a high surface-area-to-volume ratio, the invention aims to further improve the rate and efficiency of the gas-phase reaction, which may lead to even greater purity and yield by minimizing the time the cannabinoids are exposed to heat.

Key Claims at a Glance

  • The complaint asserts independent claim 1 and dependent claims 8, 14, 15, and 18 Compl. ¶242
  • The essential elements of independent claim 1 include:
    • providing a composition comprising cannabinoids wherein the composition has a surface-area-to-volume ratio greater than 1000 per meter, and which includes a native cannabinoid molecule with a carboxyl group;
    • contacting the composition with sufficient energy to convert the native molecule into a modified molecule in a gas phase;
    • contacting the modified molecule with a heat sink to condense it into a liquid distillate; and
    • collecting the liquid distillate.

U.S. Patent No. 12,297,181 - "Methods to Chemically Modify Cannabinoids"

  • Technology Synopsis: The '181 Patent claims a similar gas-phase decarboxylation method that specifically begins with an "extracted oil" from a Cannabis plant and is performed using a thin-film evaporator. The claims require specific purity outcomes, including converting less than 2% of the native cannabinoid into cannabinol (CBN) and achieving a molar ratio of the desired product to CBN of greater than 100:1 Compl. ¶¶270-271 Compl. ¶273
  • Asserted Claims: Independent claims 1, 2, and 9, and dependent claims 4, 19, and 21 Compl. ¶276
  • Accused Features: The accused features are Defendants' alleged use of short-path distillation systems, identified as a type of thin-film evaporator, to process extracted cannabis oil Compl. ¶¶278-279 Compl. ¶282

U.S. Patent No. 12,420,214 - "Methods to Produce Products Comprising Cannabinoids"

  • Technology Synopsis: The '214 Patent claims methods for producing a cannabinoid product using a specific starting composition (e.g., containing oil, less than 15% water, and at least 1% THCA) and a process involving a heated surface under vacuum. The claims also cover the act of filling a vaporizer cartridge with the resulting distillate Compl. ¶285 Compl. ¶287
  • Asserted Claims: Independent claims 1 and 18, and dependent claims 2, 4-6, 8, 11, and 19-20 Compl. ¶295
  • Accused Features: The accused features include Defendants' alleged use of thin-film evaporators (wiped-film and roller-film systems) to process cannabis extracts and the subsequent manufacture of products like Rise and &Shine-branded vaporizer cartridges containing the distillate Compl. ¶¶296-297 Compl. ¶312

III. The Accused Instrumentality

Product Identification

  • The accused instrumentalities are the processes Defendants use to manufacture cannabis distillate and the resulting products, including vaporizer cartridges and edibles sold under brands such as RYTHM, &Shine, and Rise Compl. ¶29 Compl. ¶203 Compl. ¶204

Functionality and Market Context

  • The complaint alleges that Defendants utilize short-path distillation equipment, including wiped-film and roller-film systems manufactured by companies like Chemtech Services, Inc. and Delta Separations Compl. ¶211 Compl. ¶213 These systems are alleged to function by spreading a liquid cannabis extract (containing THCA) into a thin film on a heated surface, which simultaneously vaporizes and decarboxylates the cannabinoids Compl. ¶¶215-221 A cold trap is then allegedly used as a heat sink to condense the vapor into a purified liquid distillate, which is collected to make the final products Compl. ¶¶222-224
  • The complaint positions Defendants as major operators in the cannabis market, generating over a billion dollars in annual revenue and marketing their products as high-quality and consistent, a quality Plaintiff attributes to the allegedly infringing manufacturing processes Compl. ¶11 Compl. ¶23 Compl. ¶208
  • No probative visual evidence provided in complaint.

IV. Analysis of Infringement Allegations

'248 Patent Infringement Allegations

Claim Element (from Independent Claim 1) Alleged Infringing Functionality Complaint Citation Patent Citation
providing a composition comprising cannabinoids, in which the cannabinoids comprise a native cannabinoid molecule, the native cannabinoid molecule comprises a carboxyl group, and the native cannabinoid molecule is in a liquid phase or a solid phase; Defendants provide liquid cannabis extracts containing native cannabinoids with carboxyl groups, such as THCA, as the input for their distillation systems Compl. ¶193 Compl. ¶217 Compl. ¶219 ¶¶193, 217, 219 col. 7:1-9
contacting the composition with sufficient energy to convert the native cannabinoid molecule into (i) a carbon dioxide molecule and (ii) a modified cannabinoid molecule in a gas phase; Defendants operate short-path distillation systems that heat the extracts to an elevated temperature, causing the cannabinoids to enter a gas phase and converting THCA to THC Compl. ¶¶220-221 ¶¶220-221 col. 7:10-14
contacting the modified cannabinoid molecule with a heat sink to condense the modified cannabinoid molecule into a condensed cannabinoid molecule in a liquid distillate, in which at least 95% of the native cannabinoid molecule is converted into the condensed cannabinoid molecule per mole; and Defendants' distillation systems allegedly use a cold trap, which functions as a heat sink, to condense the gas-phase THC into a liquid distillate. The complaint alleges the resulting products contain less than 0.1% THCA, which suggests a conversion rate of at least 95% Compl. ¶¶222-223 Compl. ¶¶225-226 ¶¶222-223, 225-226 col. 7:15-22
collecting the liquid distillate. Defendants are alleged to collect the resulting distillate from their systems, which is then used to manufacture consumer products Compl. ¶224 ¶224 col. 7:23-24

'402 Patent Infringement Allegations

Claim Element (from Independent Claim 1) Alleged Infringing Functionality Complaint Citation Patent Citation
providing a composition comprising cannabinoids wherein the composition has a surface-area-to-volume ratio that is greater than 1000 per meter... Defendants allegedly use wiped-film and roller-film distillation systems that spread the cannabis extract into a thin film of 100 to 500 microns on a cylindrical surface, which is alleged to create a surface-area-to-volume ratio greater than 1,000 per meter Compl. ¶¶244-248 ¶¶244-248 col. 2:50-54
...the cannabinoids comprise a native cannabinoid molecule; the native cannabinoid molecule comprises a carboxyl group; and the native cannabinoid molecule is in either a liquid phase or a solid phase; The complaint alleges Defendants' process begins with a liquid cannabis extract containing native cannabinoids like THCA and CBGA, which have carboxyl groups Compl. ¶268 ¶268 col. 2:54-58
contacting the composition with sufficient energy to convert the native cannabinoid molecule into (i) a carbon dioxide molecule and (ii) a modified cannabinoid molecule in a gas phase; The systems allegedly transfer energy via conductive heating from heated surfaces to the thin film, converting the native cannabinoids (e.g., CBGA) into modified cannabinoids (e.g., CBG) in a gas phase (Compl. ¶249; Compl. ¶250; Compl. ¶251, Compl. ¶264). ¶¶249, 251, 264 col. 2:62-65
contacting the modified cannabinoid molecule with a heat sink to condense the modified cannabinoid molecule into a condensed cannabinoid molecule in a liquid distillate; and The accused short-path distillation systems are alleged to use a cold trap as a heat sink to condense the gas-phase cannabinoids into a liquid distillate Compl. ¶265 ¶265 col. 2:66-67
collecting the liquid distillate. Defendants are alleged to collect the distillate from their systems to make and sell products containing THC, CBD, and CBG Compl. ¶266 ¶266 col. 3:1-2
  • Identified Points of Contention:
    • Technical Questions: A primary technical question will be whether Defendants' processes, as actually operated, meet the specific quantitative limitations of the claims. For the '248 Patent, this raises the question of what evidence demonstrates that "at least 95% of the native cannabinoid molecule is converted... per mole." For the '402 Patent, it raises the question of whether the "surface-area-to-volume ratio" of the composition in Defendants' equipment is, in fact, "greater than 1000 per meter" and how this ratio is to be measured in a dynamic system.
    • Scope Questions: A central scope question may be whether the term "a method to chemically modify a cannabinoid molecule" as claimed in the patents, which describe a novel gas-phase reaction, can be read to encompass the use of conventional short-path distillation equipment. Defendants may argue their process is primarily for purification, a standard industrial technique, and that any decarboxylation is an incidental, well-known consequence of heating, rather than the specific, controlled gas-phase modification method described in the patents.

V. Key Claim Terms for Construction

  • The Term: "sufficient energy" '248 Patent, claim 1 '402 Patent, claim 1

    • Context and Importance: The definition of "sufficient energy" is critical because it is the input that allegedly enables the patented gas-phase decarboxylation. Practitioners may focus on this term because the dispute may center on whether the heating in Defendants' standard distillation equipment is merely for vaporization (a known process) or if it constitutes the specific application of energy required to perform the patented chemical modification.
    • Intrinsic Evidence for Interpretation:
      • Evidence for a Broader Interpretation: The specifications disclose that the energy can be applied through various means, including conductive, convective, or radiative heating, and provide broad quantitative ranges (e.g., "2 kJ to 50 kJ per gram"), which could support a broad reading covering many forms of heating that result in vaporization '248 Patent, col. 11:21-23 '248 Patent, col. 11:35-43
      • Evidence for a Narrower Interpretation: The patents frame the invention as a way to lower the activation energy of decarboxylation by performing it in the gas phase, distinguishing it from prolonged liquid-phase heating '248 Patent, col. 1:15-23 '248 Patent, col. 5:8-11 This context may support a narrower interpretation where "sufficient energy" must be applied in a manner specifically tailored to facilitate this rapid gas-phase reaction, not just general heating for distillation.

  • The Term: "surface-area-to-volume ratio" ('402 Patent, claim 1; '181 Patent, claim 1)

    • Context and Importance: This term introduces a specific, quantifiable geometric constraint that is central to the infringement allegations for the '402 and '181 Patents. The case may turn on how this ratio is defined and measured for the "composition" within Defendants' dynamic wiped-film or roller-film systems.
    • Intrinsic Evidence for Interpretation:
      • Evidence for a Broader Interpretation: The claim language states "providing a composition... wherein the composition has a surface-area-to-volume ratio..." '402 Patent, claim 1 Plaintiff may argue this ratio applies to the state of the composition as it is being processed (i.e., as a thin film), consistent with the complaint's allegation that a 100-500 micron film achieves the claimed ratio Compl. ¶¶247-248
      • Evidence for a Narrower Interpretation: A defendant could argue that the plain language requires the "composition" to have this ratio at the "providing" step, before energy is applied. This could support an argument that a bulk liquid, which is only later spread into a thin film, does not meet the limitation as claimed, creating a potential non-infringement argument based on the timing and sequence of the process steps.

VI. Other Allegations

  • Indirect Infringement: The complaint makes extensive allegations of induced infringement against the parent company, Green Thumb Industries Inc. (GTI). It alleges GTI actively and knowingly instructs and directs its subsidiaries, including KSGNF III, to use the allegedly infringing processes by establishing and enforcing standard operating procedures Compl. ¶321 Compl. ¶327 Compl. ¶343 The complaint further alleges GTI controls the manufacture and sale of the resulting products made by its subsidiaries Compl. ¶323 Compl. ¶339
  • Willful Infringement: While not using the term "willful" in the infringement counts, the complaint requests enhanced damages under 35 U.S.C. § 284 Compl., Prayer for Relief (e) The basis for this appears to be post-suit knowledge, as the complaint alleges Defendants have had "actual knowledge" of the asserted patents "at least as of the filing date of this complaint" Compl. ¶319 Compl. ¶335 Compl. ¶351 Compl. ¶367

VII. Analyst's Conclusion: Key Questions for the Case

  • A central issue will be one of technical proof: can the plaintiff provide sufficient evidence to demonstrate that the Defendants' commercial-scale distillation equipment, as actually operated, meets the specific quantitative limitations recited in the claims, such as the "surface-area-to-volume ratio greater than 1000 per meter" of the '402 patent and the "at least 95%... converted per mole" of the '248 patent?
  • A key legal question will be one of inventive scope: does the Defendants' alleged use of short-path distillation-a known technique for purification-constitute an infringement of patents that describe and claim a specific method for chemical modification via a rapid, gas-phase decarboxylation reaction, or is there a fundamental mismatch between the accused industrial process and the patented invention?
  • A significant procedural question will be one of corporate liability: given the complex corporate structure, can the plaintiff successfully establish that the parent company, GTI, exerted sufficient control over its subsidiaries to be held directly liable for their alleged infringement under an alter ego or agency theory, as extensively pleaded in the complaint?
Loading Complaint